Categories: News

3Win Corp. Executes Definitive Agreement to Acquire Serenus Global, Inc.

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

TEMPE, AZ / ACCESSWIRE / December 5, 2023 / 3Win Corp., a Tempe, Arizona-based global wholesale distributor of CCELL® vape products announces today that it has entered into a definitive agreement to acquire Serenus Global, Inc., a Vancouver, British Columbia-based multi-disciplinary controlled substances company. While Serenus will operate independently as a wholly owned subsidiary of 3Win, the management teams and Boards will combine, bringing new vision and opportunities to both companies. The acquisition is expected to close on or around December 12, 2023, after approval of the acquisition by Serenus shareholders.

3win

“We are extremely excited to combine with the talented management team at Serenus,” said Christopher Sinacori, Chief Executive Officer of 3Win. “Together, we will bring our products to new and emerging markets to satisfy a rapidly growing consumer base. We believe our combined management team will provide unparalleled experience in the international distribution and marketing of safe, highest-quality controlled substances for both medical and recreational purposes. The future in the psychedelic sector is our next big growth opportunity, and Serenus gives us a unique advantage in this space.”

“Chris and the 3Win team have built an extraordinary company, and I am excited to bring our expertise, experience, and cutting-edge technologies in the cannabis and psychedelic industries into the 3Win family,” said Rodney Hu, Executive Chairman of Serenus. “I believe we will have an even greater opportunity together to expand into the global marketplace.”

About 3Win Corp.
3Win Corp. is a global wholesale distributor of high-quality, research-backed CCELL® vape products to the cannabis and hemp industry. As the preferred wholesale distributor of CCELL® products, from the leading vape hardware manufacture, Shenzhen Smoore Technology, Limited, 3Win offers the highest-quality products to protect product integrity, promote safe user experiences, and build brand identity. CCELL® products feature patented ceramic heating elements that deliver safe, pure-flavored pulls with every use. In addition to CCELL® products, 3Win provides customers with stateside customization services and packaging to ensure brands will stand out in a crowded marketplace. Visit www.3wincorp.com for more information.

About Serenus Global, Inc.
Serenus Global is one of the world’s first multi-disciplinary controlled substances companies. Serenus is dedicated to the production and supply of consistent and compliant materials for medical and adult-use markets, and enhancing well-being through the educated use of controlled substances. As new markets emerge, and research and medical developments expand, Serenus is committed to being a trusted team that is recognized for advancing industry development. Visit www.serenusglobal.com for more information.

Forward-looking statements
3Win cautions you that statements in this news release that are not a description of historical facts are forward-looking statements. These statements are based on our current beliefs and expectations. The inclusion of forward-looking statements should not be regarded as a representation that any of our plans will be achieved. Actual results may differ from those set forth in this news release due to the risk and uncertainties inherent in our business.

Media Contact
Paul Burgess
3Win Corp.
(732) 245-1342
IR@3wincorp.com

Contact Information
Paul Burgess
ir@3wincorp.com
(732)245-1342

SOURCE: 3Win Corp.

View source version on accesswire.com:
https://www.accesswire.com/813188/3win-corp-executes-definitive-agreement-to-acquire-serenus-global-inc

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

1 day ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

1 day ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

1 day ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

1 day ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

1 day ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

1 day ago